A Genetic Animal Model of Differential Sensitivity to Methamphetamine Reinforcement

Overview

Journal Neuropharmacology

Specialties Neurology
Pharmacology

Date 2012 Jan 28

PMID 22280875

Citations 35

Authors

Shkelzen Shabani

Lauren K Dobbs

Matthew M Ford

Gregory P Mark

Deborah A Finn

Tamara J Phillips

Affiliations

Soon will be listed here.

Abstract

Sensitivity to reinforcement from methamphetamine (MA) likely influences risk for MA addiction, and genetic differences are one source of individual variation. Generation of two sets of selectively bred mouse lines for high and low MA drinking has shown that genetic factors influence MA intake, and pronounced differences in sensitivity to rewarding and aversive effects of MA play a significant role. Further validation of these lines as a unique genetic model relevant to MA addiction was obtained using operant methods to study MA reinforcement. High and low MA drinking line mice were used to test the hypotheses that: 1) oral and intracerebroventricular (ICV) MA serve as behavioral reinforcers, and 2) MA exhibits greater reinforcing efficacy in high than low MA drinking mice. Operant responses resulted in access to an MA or non-MA drinking tube or intracranial delivery of MA. Behavioral activation consequent to orally consumed MA was determined. MA available for consumption maintained higher levels of reinforced instrumental responding in high than low MA drinking line mice, and MA intake in the oral operant procedure was greater in high than low MA drinking line mice. Behavioral activation was associated with amount of MA consumed during operant sessions. High line mice delivered more MA via ICV infusion than did low line mice across a range of doses. Thus, genetic risk factors play a critical role in the reinforcing efficacy of MA and the oral self-administration procedure is suitable for delineating genetic contributions to MA reinforcement.

Citing Articles

Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice.

Fultz E, Nei A, Chi J, Lichter J, Szumlinski K Front Psychiatry. 2024; 15:1297275.

PMID: 38638417 PMC: 11024460. DOI: 10.3389/fpsyt.2024.1297275.

Rats have low motivation to self-administer oral methamphetamine across increasing response requirements.

Yates J, Berling K, Broderick M, Bako R, Dillon S Behav Brain Res. 2023; 455:114673.

PMID: 37717660 PMC: 10591766. DOI: 10.1016/j.bbr.2023.114673.

GDNF gene therapy for alcohol use disorder in male non-human primates.

Ford M, George B, Van Laar V, Holleran K, Naidoo J, Hadaczek P Nat Med. 2023; 29(8):2030-2040.

PMID: 37580533 PMC: 10602124. DOI: 10.1038/s41591-023-02463-9.

Robust aversive effects of trace amine-associated receptor 1 activation in mice.

Shabani S, Houlton S, Ghimire B, Tonello D, Reed C, Baba H Neuropsychopharmacology. 2023; 48(10):1446-1454.

PMID: 37055488 PMC: 10425385. DOI: 10.1038/s41386-023-01578-4.

Midazolam, methamphetamine, morphine and nicotine intake in high-drinking-in-the-dark mice.

Savarese A, Metten P, Phillips T, Jensen B, Crabbe J, Ozburn A Addict Biol. 2022; 27(5):e13212.

PMID: 36001437 PMC: 9677807. DOI: 10.1111/adb.13212.

References

Zweben J, Cohen J, Christian D, Galloway G, Salinardi M, Parent D . Psychiatric symptoms in methamphetamine users. Am J Addict. 2004; 13(2):181-90. DOI: 10.1080/10550490490436055. View

Bryant C, Chang H, Zhang J, Wiltshire T, Tarantino L, Palmer A . A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav. 2009; 8(8):795-805. PMC: 3697834. DOI: 10.1111/j.1601-183X.2009.00525.x. View

Zapata A, Minney V, Shippenberg T . Shift from goal-directed to habitual cocaine seeking after prolonged experience in rats. J Neurosci. 2010; 30(46):15457-63. PMC: 3073559. DOI: 10.1523/JNEUROSCI.4072-10.2010. View

Johnson R, Beltz T, Thunhorst R, Johnson A . Investigations on the physiological controls of water and saline intake in C57BL/6 mice. Am J Physiol Regul Integr Comp Physiol. 2003; 285(2):R394-403. DOI: 10.1152/ajpregu.00130.2003. View

Simon N, Mendez I, Setlow B . Effects of prior amphetamine exposure on approach strategy in appetitive Pavlovian conditioning in rats. Psychopharmacology (Berl). 2008; 202(4):699-709. PMC: 7450361. DOI: 10.1007/s00213-008-1353-y. View

Lederle L, Weber S, Wright T, Feyder M, Brigman J, Crombag H . Reward-related behavioral paradigms for addiction research in the mouse: performance of common inbred strains. PLoS One. 2011; 6(1):e15536. PMC: 3018410. DOI: 10.1371/journal.pone.0015536. View

Shabani S, McKinnon C, Cunningham C, Phillips T . Profound reduction in sensitivity to the aversive effects of methamphetamine in mice bred for high methamphetamine intake. Neuropharmacology. 2011; 62(2):1134-41. PMC: 3297479. DOI: 10.1016/j.neuropharm.2011.11.005. View

Kirstein S, Davidson K, Ehringer M, Sikela J, Erwin V, Tabakoff B . Quantitative trait loci affecting initial sensitivity and acute functional tolerance to ethanol-induced ataxia and brain cAMP signaling in BXD recombinant inbred mice. J Pharmacol Exp Ther. 2002; 302(3):1238-45. DOI: 10.1124/jpet.302.3.1238. View

Wheeler J, Reed C, Burkhart-Kasch S, Li N, Cunningham C, Janowsky A . Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes Brain Behav. 2009; 8(8):758-71. PMC: 2783502. DOI: 10.1111/j.1601-183X.2009.00522.x. View

10.

Heyne A, Wolffgramm J . The development of addiction to d-amphetamine in an animal model: same principles as for alcohol and opiate. Psychopharmacology (Berl). 1999; 140(4):510-8. DOI: 10.1007/s002130050796. View

11.

Crabbe J, Phillips T, Buck K, Cunningham C, Belknap J . Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci. 1999; 22(4):173-9. DOI: 10.1016/s0166-2236(99)01393-4. View

12.

Phillips T, Huson M, McKinnon C . Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J Neurosci. 1998; 18(8):3023-34. PMC: 6792576. View

13.

Palmer A, Verbitsky M, Suresh R, Kamens H, Reed C, Li N . Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome. 2005; 16(5):291-305. DOI: 10.1007/s00335-004-2451-8. View

14.

Samson H, Czachowski C . Behavioral measures of alcohol self-administration and intake control: rodent models. Int Rev Neurobiol. 2003; 54:107-43. DOI: 10.1016/s0074-7742(03)54004-1. View

15.

George F, Elmer G, Meisch R, Goldberg S . Orally delivered cocaine functions as a positive reinforcer in C57BL/6J mice. Pharmacol Biochem Behav. 1991; 38(4):897-903. DOI: 10.1016/0091-3057(91)90260-9. View

16.

Sharpe A, SAMSON H . Effect of naloxone on appetitive and consummatory phases of ethanol self-administration. Alcohol Clin Exp Res. 2001; 25(7):1006-11. View

17.

Phillips T, Kamens H, Wheeler J . Behavioral genetic contributions to the study of addiction-related amphetamine effects. Neurosci Biobehav Rev. 2008; 32(4):707-59. PMC: 2360482. DOI: 10.1016/j.neubiorev.2007.10.008. View

18.

Pierce R, Kalivas P . A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997; 25(2):192-216. DOI: 10.1016/s0165-0173(97)00021-0. View

19.

Grilly D, Loveland A . What is a "low dose" of d-amphetamine for inducing behavioral effects in laboratory rats?. Psychopharmacology (Berl). 2001; 153(2):155-69. DOI: 10.1007/s002130000580. View

20.

Thomsen M, Caine S . Intravenous drug self-administration in mice: practical considerations. Behav Genet. 2007; 37(1):101-18. DOI: 10.1007/s10519-006-9097-0. View